We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Fireaway pizza orginally started out as a modest pizzeria in south London in 2016, we've expanded to 159 franchises, achieving a remarkable 106% compound annual growth rate in store expansion. With franchise sales reaching £59 million annually, we became debt-free in 2022, boasting an EBITDA of £1.31 million and HQ revenue of £14.5 million in FY23. As a profitable venture, we invite you to join us and be part of our promising growth trajectory.
days to go: Expired investment: £532,336
Aardvark is a company that manufactures dry kibbles for dogs and cats using insects as the source of protein. It has partnered with VC backed insect farm NextProtein. The company claims that its products meet the nutritional needs of pets while creating a smaller environmental footprint than pet food that uses animal meat. It also asserts that insect protein is endorsed by the British Veterinary Association. The company has developed its kibbles to be grain-free, consist of seaweed and other natural ingredients with no fillers. The UK pet food market is poised to grow to £2.9 billion in 2020, and the company aims to be a sustainable manufacturer in this segment.  The company requires investment to assist in manufacturing its first batch of pet food, help market its products to pet owners across the UK, and expand into Europe by 2021 and the U.S by 2024.
days to go: Expired investment: £300,290
Oatsu specializes in providing a convenient and healthy breakfast option with their freshly-prepared overnight oats. Recognizing the increasing demand for overnight oats due to their popularity (ranking as the 4th most Googled recipe globally with a 4600% increase in searches since 2014), Oatsu offers a solution to the time-consuming preparation process. They've served over 20,000 breakfasts to 2,744 customers and businesses throughout the UK. Oatsu's approach involves soaking oats in oat milk and incorporating fruit and seeds to create four delicious flavors, including a collaboration with ManiLife, all of which are plant-based and packaged in recyclable materials.
days to go: Expired investment: £249,443
Landbay is a Buy-to Mortgage (BTM) lending platform that provides investors access to a flow of whole-loan high-quality BTL mortgages that can be securitised or held on a balance sheet. Landbay asserts that it does not deploy any of its own balance sheet nor take any credit risk. The company has completed over £600 million of mortgages to date. It argues that it has the mortgage funding, technology and capacity to grow significantly in the £250 billion mortgage market. The company was rated 'Excellent' on consumer review website Trustpilot. It will use 50% of the investment towards technology upgrade, 25% towards marketing and brand development, and 25% towards general marketing expenses.
days to go: Expired investment: £5,129,548
Selling over 800 beers across two award-winning brands: We Brought Beer and The Beer Boutique, as well as being one of the UK's largest independent craft beer retailers, Two Heads Beer Co. is seeking investment to further expand the business with 4 new stores already planned in addition to the existing 6 stores with almost £1 million in revenue.

Pitch Rated

64%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £375,040
An award-winning independent brewery that has been profitable every year since 2014 with worldwide distribution. Siren Craft Brew creates beers to ease those new to drinking, whilst producing adventurous flavours to continuously recapture and entice customers to return to their products. The business has won numerous awards for their beers. In their first year of launching, Ratebeer.com rated Siren Craft Brew as the 2nd Best New Brewery in the World and is repeatedly listed in their Top 100 Brewers every year. They have also been awarded the World Beer Cup medal and CAMRA’s Supreme Champion Beer of Britain for their flagship stout. Siren Craft Brew consists of a team of 28 people, whilst achieving £2.82m in annual turnover. In 2018 so far, their revenue has grown by 28% and their brewery has produced more than 2m pints this year. The company is now raising funds to package their products into cans, as they have already identified a canning manufacturer that will meet the business's needs to also create high-quality bottles for their beer. Any overfunding will result in the company being able to take their taproom experience to other areas, as well as increase beer production and produce drinks in a more efficient manner.
days to go: Expired investment: £1,215,170
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph